HEOR for Diagnostics
The clinical lab community needs a shared vision for calculating the value of diagnostic testing.
Read MorePosted by Elaine Sanchez Wilson | Jul 17, 2017 | Cancer |
The clinical lab community needs a shared vision for calculating the value of diagnostic testing.
Read MorePosted by Elaine Sanchez Wilson | Jul 17, 2017 | Research, Urinalysis & Toxicology |
Manufacturers are leveraging global insights to address the emerging needs of US laboratories.
Read MorePosted by Elaine Sanchez Wilson | Jul 10, 2017 | Cancer, Molecular Diagnostics |
Real-world data enables researchers to test hypotheses in advance of clinical trials.
Read MorePosted by Elaine Sanchez Wilson | Jun 6, 2017 | Uncategorized, Urinalysis & Toxicology |
OGT will become a wholly owned subsidiary of Sysmex.
Read MorePosted by Elaine Sanchez Wilson | Jun 5, 2017 | Disease States |
A number of oncology centers have developed and implemented liquid biopsy tests not only for lung cancer, but for breast, colorectal, gynecologic, ovarian, prostate, and skin cancers as well.
Read More